Bradner James E. - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Bradner James E.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2026-05-07
Tax Withholding
2026-05-11
7:36 pm
N/A
N/A
AMGEN INCAMGNBradner James E.
EVP, Research and Development
446$331.1130,016
(Direct)
View
2026-05-06
Tax Withholding
2026-05-07
9:14 pm
N/A
N/A
AMGEN INCAMGNBradner James E.
EVP, Research and Development
407$329.5952,235
(Direct)
View
2026-05-05
Option Award
2026-05-07
9:14 pm
2027-05-05
2036-05-05
AMGEN INCAMGNBradner James E.
EVP, Research and Development
21,773$329.5952,235
(Direct)
View
2026-05-05
Option Award
2026-05-07
9:14 pm
N/A
N/A
AMGEN INCAMGNBradner James E.
EVP, Research and Development
3,337$052,235
(Direct)
View
2026-02-09
Tax Withholding
2026-02-10
6:39 pm
N/A
N/A
AMGEN INCAMGNBradner James E.
EVP, Research and Development
3,104$384.3227,378
(Direct)
View
2025-05-06
Option Award
2025-05-08
8:49 pm
2026-05-06
2035-05-06
AMGEN INCAMGNBradner James E.
EVP, R&D, & Chief Sci. Officer
22,944$270.4452,697
(Direct)
View
2025-05-06
Option Award
2025-05-08
8:49 pm
N/A
N/A
AMGEN INCAMGNBradner James E.
EVP, R&D, & Chief Sci. Officer
3,549$052,697
(Direct)
View
2024-05-07
Option Award
2024-05-09
6:59 pm
2026-05-07
2034-05-07
AMGEN INCAMGNBradner James E.
EVP, R&D, & Chief Sci. Officer
18,603$300.344,041
(Direct)
View
2024-05-07
Option Award
2024-05-09
6:59 pm
N/A
N/A
AMGEN INCAMGNBradner James E.
EVP, R&D, & Chief Sci. Officer
2,863$044,041
(Direct)
View
2024-02-09
Option Award
2024-02-12
7:50 pm
N/A
N/A
AMGEN INCAMGNBradner James E.
EVP, R&D, & Chief Sci. Officer
22,393$022,393
(Direct)
View